Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) Operating Margin: 2020-2024

Historic Operating Margin for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to 69.32%.

  • Burning Rock Biotech's Operating Margin rose 2174.00% to 12.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.49%, marking a year-over-year increase of 6561.00%. This contributed to the annual value of 69.32% for FY2024, which is 5522.00% up from last year.
  • Burning Rock Biotech's Operating Margin amounted to 69.32% in FY2024, which was up 44.34% from 124.54% recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Operating Margin ranged from a high of 69.32% in FY2024 and a low of 174.07% during FY2022.
  • Its 3-year average for Operating Margin is 122.64%, with a median of 124.54% in 2023.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by 6,102bps in 2021, then soared by 5,522bps in 2024.
  • Burning Rock Biotech's Operating Margin (MRY) stood at 95.93% in 2020, then crashed by 64bps to 156.95% in 2021, then fell by 11bps to 174.07% in 2022, then rose by 28bps to 124.54% in 2023, then surged by 44bps to 69.32% in 2024.
  • Its Operating Margin stands at 69.32% for FY2024, versus 124.54% for FY2023 and 174.07% for FY2022.